You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Unresectable Renal Pelvic and Ureteral Neoplasms

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Pelvic and Ureteral Tumors Trial in Guangzhou (rreversible electroporation (IRE), NanoKnife)

Completed
  • Renal Pelvic and Ureteral Neoplasms
  • rreversible electroporation (IRE)
  • NanoKnife
  • Guangzhou, Guangdong, China
    Biological treatment center in Fuda cancer hospital
Sep 1, 2021

Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

Not yet recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +31 more
  • Diagnostic Laboratory Biomarker Analysis
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma Trial in

Recruiting
  • Advanced Bladder Urothelial Carcinoma
  • +23 more
  • Riverside, California
  • +8 more
Jul 16, 2022

Bladder Squamous Cell Carcinoma, Locally Advanced Bladder Carcinoma, Malignant Renal Pelvis Tumor Trial in Atlanta (procedure,

Not yet recruiting
  • Bladder Squamous Cell Carcinoma
  • +10 more
  • Biospecimen Collection
  • +5 more
  • Atlanta, Georgia
  • +3 more
Feb 20, 2023

Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter Urothelial Carcinoma, Locally Advanced Urethral

Recruiting
  • Locally Advanced Renal Pelvis Urothelial Carcinoma
  • +20 more
  • Duarte, California
  • +16 more
Aug 10, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +41 more
  • Ipilimumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 11, 2022

Renal Cell Carcinoma, Adrenal Tumor, Nonfunctioning Kidney Trial (telesurgery by domestic surgical robot)

Not yet recruiting
  • Renal Cell Carcinoma
  • +13 more
  • telesurgery by domestic surgical robot
  • (no location specified)
Feb 12, 2023

Cancer, Urinary Obstruction, Malignancy Trial in Chicago (Ureteral Stent, Percutaneous Nephrostomy Tube Placement)

Not yet recruiting
  • Cancer
  • +5 more
  • Ureteral Stent
  • Percutaneous Nephrostomy Tube Placement
  • Chicago, Illinois
    The University of Chicago
Nov 28, 2022

Recurrent Endometrial Carcinoma, Unresectable Endometrial Carcinoma Trial in Miami (Lenvatinib, Pembrolizumab, Hypofractionated

Not yet recruiting
  • Recurrent Endometrial Carcinoma
  • Unresectable Endometrial Carcinoma
  • Miami, Florida
    University of Miami
Jan 10, 2023

Hypertension, Uncontrolled Hypertension Trial in Tbilisi (Renal Pelvic Denervation (bilateral))

Active, not recruiting
  • Hypertension
  • Uncontrolled Hypertension
  • Renal Pelvic Denervation (bilateral)
  • Tbilisi, Georgia
  • +1 more
Jun 30, 2022

Urological Malignancies, Prostate Cancer, Renal Cell Cancer Trial in Seoul

Recruiting
  • Urological Malignancies
  • +4 more
    • Seoul, Korea, Republic of
      Yonsei Severance Hospital
    Jan 30, 2023

    Primary and Metastatic Tumors in Renal Cell Carcinoma and

    Recruiting
    • Renal Cell Carcinoma
    • +4 more
    • Immune checkpoint inhibitor targeting PD1
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center - Philadelphia
    Jan 27, 2023

    Melanoma, Urothelial Carcinoma, Renal Cell Carcinoma Trial in Auchenflower (RC198 Injection)

    Not yet recruiting
    • Melanoma
    • +5 more
    • RC198 Injection
    • Auchenflower, Queensland, Australia
      Research Site
    May 17, 2023

    A Genotype-Phenotype Urothelial Cancer Registry

    Recruiting
    • Urothelial Cancer
    • +3 more
    • saliva sample and questionaire
    • saliva sample, questionaire
    • Basking Ridge, New Jersey
    • +3 more
    Jun 2, 2022

    Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

    Recruiting
    • Locally Advanced Bladder Urothelial Carcinoma
    • +13 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Jun 8, 2022

    Renal Tumor Trial in Guangzhou (irreversible electroporation)

    Completed
    • Renal Tumor
    • irreversible electroporation
    • Guangzhou, Guangdong, China
      Fuda Cancer Hospital
    Sep 1, 2021

    Ureteral Tumors Trial in Roskilde (Lymphadenectomy in conjugation with nephroureterectomy, Nephroureterectomy without

    Recruiting
    • Ureteral Neoplasms
    • Lymphadenectomy in conjugation with nephroureterectomy
    • Nephroureterectomy without lymphadenectomy
    • Roskilde, Denmark
      Roskilde Hospital
    Sep 16, 2021

    Hydronephrosis, Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma,

    Active, not recruiting
    • Hydronephrosis
    • +18 more
    • Durvalumab
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 31, 2022

    Renal Cell Carcinoma, NSCLC, Pancreatic Adenocarcinoma, Colorectal Cancer Trial (RO7515629, tocilizumab)

    Not yet recruiting
    • Renal Cell Carcinoma, Non-small Cell Lung Cancer, Pancreatic Adenocarcinoma, Colorectal Cancer
    • (no location specified)
    Mar 3, 2023

    Stage 0a Renal Pelvis and Ureter Cancer AJCC v8, Stage 0a Renal Pelvis Cancer AJCC v8, Stage 0a Ureter Cancer AJCC v8 Trial in

    Active, not recruiting
    • Stage 0a Renal Pelvis and Ureter Cancer AJCC v8
    • +17 more
    • Gemcitabine Hydrochloride
    • Jacksonville, Florida
    • +3 more
    Jul 5, 2022

    Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

    Recruiting
    • Locally Advanced Bladder Urothelial Carcinoma
    • +18 more
    • Los Angeles, California
    • +2 more
    Jun 28, 2022

    Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous

    Not yet recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +12 more
    • Biopsy
    • +8 more
    • (no location specified)
    Jun 8, 2023

    Observe Onset of Immune-related Adverse Reactions in

    Completed
    • Renal Cell Carcinoma
    • Kidney Cancer
    • Non-Interventional
    • Tokyo, Japan
      Local Institution
    Feb 9, 2022

    Urothelial Cancer, Metastatic Urothelial Carcinoma, Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter Trial in

    Recruiting
    • Urothelial Cancer
    • +3 more
    • Sacituzumab Govitecan (SG)
    • Enfortumab vedotin-ejfv (EV)
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Sep 28, 2022

    Advanced Clear Cell Renal Cell Carcinoma, Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant, Infiltrating Bladder

    Active, not recruiting
    • Advanced Clear Cell Renal Cell Carcinoma
    • +35 more
    • Cabozantinib S-malate
    • +2 more
    • Duarte, California
    • +7 more
    Jan 3, 2023